Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients

被引：10
作者：
Shah, Rajiv [1 ]
Baqai-Stern, Aisha [2 ]
Gulati, Amitabh [2 ]
机构：
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, Board Certified Anesthesiol & Pain Management, M308, New York, NY 10065 USA
来源：
CURRENT PAIN AND HEADACHE REPORTS | 2015年 / 19卷 / 06期
关键词：
Intrathecal drug delivery; Intrathecal medications; Cancer pain; Neuraxial trial; CHRONIC PAIN; MANAGEMENT; RECOMMENDATIONS; SELECTION; THERAPY; SYSTEM; IMPACT;
D O I：
10.1007/s11916-015-0488-x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient's disease course, and the management of complications related to the ITDD system and intrathecal medications.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Catheter-tip Granulomas Associated with Intrathecal Drug Delivery - A Two-Center Experience Identifying 13 Cases
    Kratzsch, Tobias
    Stienen, Martin N.
    Reck, Tim
    Hildebrandt, Gerhard
    Hoederath, Petra
    PAIN PHYSICIAN, 2015, 18 (05) : E831 - E840
  • [42] Complications of intrathecal drug delivery systems
    Kamran, S
    Wright, BD
    NEUROMODULATION, 2001, 4 (03): : 111 - 115
  • [43] The Application of Failure Modes and Effects Analysis Methodology to Intrathecal Drug Delivery for Pain Management
    Saulino, Michael F.
    Patel, Teresa
    Fisher, Stanley P.
    NEUROMODULATION, 2017, 20 (02): : 177 - 186
  • [44] Medical Cost Impact of Intrathecal Drug Delivery for Noncancer Pain
    Guillemette, Scott
    Witzke, Susan
    Leier, Jacqueline
    Hinnenthal, Jennifer
    Prager, Joshua P.
    PAIN MEDICINE, 2013, 14 (04) : 504 - 515
  • [45] Considerations for Evaluating the Use of Intrathecal Drug Delivery in the Oncologic Patient
    Amitabh Gulati
    Vinay Puttanniah
    Joseph Hung
    Vivek Malhotra
    Current Pain and Headache Reports, 2014, 18
  • [46] Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center
    Sayed, Dawood
    Monroe, Forrest
    Orr, Walter N.
    Phadnis, Milind
    Khan, Talal W.
    Braun, Edward
    Manion, Smith
    Nicol, Andrea
    NEUROMODULATION, 2018, 21 (07): : 660 - 664
  • [47] Management of Refractory Cancer Pain with Intrathecal Drug Delivery and Spinal Cord Stimulation
    Bulat, Evgeny
    Crowther, Jason E.
    Chakravarthy, Vikram
    Laufer, Ilya
    Barzilai, Ori
    Gulati, Amitabh
    PALLIATIVE MEDICINE REPORTS, 2024, 5 (01): : 301 - 305
  • [48] Efficacy of intrathecal drug delivery system for refractory cancer pain patients: A single tertiary medical center experience
    Lin, Chih-Peng
    Lin, Wen-Ying
    Lin, Feng-Sheng
    Lee, Yow-Shan
    Jeng, Chuen-Shin
    Sun, Wei-Zen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (05) : 253 - 257
  • [49] Management of a Cancer Patient with an Intrathecal Drug Delivery System and an Acute Brain Abscess
    Walega, David R.
    Korn, Marc
    JOURNAL OF PALLIATIVE MEDICINE, 2018, 21 (05) : 727 - 729
  • [50] Effects of an Intrathecal Drug Delivery System Connected to a Subcutaneous Port on Pain, Mood and Quality of Life in End Stage Cancer Patients: An Observational Study
    Giglio, Mariateresa
    Preziosa, Angela
    Mele, Roberta
    Brienza, Nicola
    Grasso, Salvatore
    Puntillo, Filomena
    CANCER CONTROL, 2022, 29
12345